Among the 22 patients with favorable‐risk cytogenetic AML, patients with KIT mutation had significantly poorer OS (HR = 7.002, 95% CI: 1.925–25.467, P = 0.003). The gene discussed is KIT; the disease is acute myeloid leukemia.